Theregen, Inc. is a regenerative medicine company that is developing cell-based therapies
for cardiovascular indications. Anginera™, Theregen's lead product, is an epicardial patch designed to improve cardiac function in patients.

What's new?

Anginera Patch Used as Foundation for Beating Heart Cell Patch (pdf)
Theregen News Release - 07/30/09

Researchers Create Beating Heart Cells Patch;
Anginera Used as Foundation
NPR - ScienceFriday 07/24/09

Progress in Tissue Engineering (4.7 MB pdf)
Scientific American 05/09


 

---